Fundraising Fox
Ensemtx
Cambridge, US · Founded 2021 · 20 employees on LinkedIn · 2 known investors
Find your way into Ensemtx
Sign up to see every warm intro you have to Ensemtx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ensemtx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ensem Therapeutics is a drug discovery and development company focused on oncology therapeutics, leveraging proprietary computational chemistry and protein structural dynamics platforms. The company advances small molecule and targeted therapies from discovery through clinical development.
Founders & leadership
Ensemtx was founded in 2021 by Shengfang Jin.
SJ
Shengfang JinPresident and CEO, Board of DirectorShengfang Jin is President and CEO of Ensem Therapeutics, a drug discovery company developing oncology therapeutics. With over 25 years of biotech research experience in the Greater Boston area, he has led teams in developing small molecules and therapies for cancer and rare genetic diseases.
Investors · 2
Frequently asked questions
- What does Ensemtx do?
- Ensem Therapeutics is a drug discovery and development company focused on oncology therapeutics, leveraging proprietary computational chemistry and protein structural dynamics platforms. The company advances small molecule and targeted therapies from discovery through clinical development.
- Who founded Ensemtx?
- Ensemtx was founded by Shengfang Jin in 2021.
- Who are Ensemtx's investors?
- Ensemtx's investors include GGV Capital, Cenova Capital.
- Where is Ensemtx headquartered?
- Ensemtx is headquartered in Cambridge, US.